Ellis V - Search Results

1

Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.

Ellis V, Danø K. Ellis V, et al. J Biol Chem. 1993 Mar 5;268(7):4806-13. J Biol Chem. 1993. PMID: 8444857 Free article.

2

The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria.

Ploug M, Plesner T, Rønne E, Ellis V, Høyer-Hansen G, Hansen NE, Danø K. Ploug M, et al. Among authors: ellis v. Blood. 1992 Mar 15;79(6):1447-55. Blood. 1992. PMID: 1312369 Free article.

3

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.

Ellis V, Pyke C, Eriksen J, Solberg H, Danø K. Ellis V, et al. Ann N Y Acad Sci. 1992 Dec 4;667:13-31. doi: 10.1111/j.1749-6632.1992.tb51591.x. Ann N Y Acad Sci. 1992. PMID: 1339241 Review. No abstract available.

4

Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.

Høyer-Hansen G, Rønne E, Solberg H, Behrendt N, Ploug M, Lund LR, Ellis V, Danø K. Høyer-Hansen G, et al. Among authors: ellis v. J Biol Chem. 1992 Sep 5;267(25):18224-9. J Biol Chem. 1992. PMID: 1381366 Free article.

5

Plasminogen activation by receptor-bound urokinase.

Ellis V, Danø K. Ellis V, et al. Semin Thromb Hemost. 1991 Jul;17(3):194-200. doi: 10.1055/s-2007-1002609. Semin Thromb Hemost. 1991. PMID: 1665584 Review. No abstract available.

6

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor.

Rønne E, Behrendt N, Ellis V, Ploug M, Danø K, Høyer-Hansen G. Rønne E, et al. Among authors: ellis v. FEBS Lett. 1991 Aug 19;288(1-2):233-6. doi: 10.1016/0014-5793(91)81042-7. FEBS Lett. 1991. PMID: 1715292 Free article.

7

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor.

Ellis V, Behrendt N, Danø K. Ellis V, et al. J Biol Chem. 1991 Jul 5;266(19):12752-8. J Biol Chem. 1991. PMID: 1829461 Free article.

8

Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.

Ellis V, Wun TC, Behrendt N, Rønne E, Danø K. Ellis V, et al. J Biol Chem. 1990 Jun 15;265(17):9904-8. J Biol Chem. 1990. PMID: 2161846 Free article.

9

Chemical modification of the urokinase-type plasminogen activator and its receptor using tetranitromethane. Evidence for the involvement of specific tyrosine residues in both molecules during receptor-ligand interaction.

Ploug M, Rahbek-Nielsen H, Ellis V, Roepstorff P, Danø K. Ploug M, et al. Among authors: ellis v. Biochemistry. 1995 Oct 3;34(39):12524-34. doi: 10.1021/bi00039a006. Biochemistry. 1995. PMID: 7548000

The NH2-terminal domain of uPAR has a primary role in uPA binding, although maintenance of its multidomain structure has been shown to be necessary for the high affinity of this interaction [Ploug, M., Ellis, V., & Dano, K. (1994) Biochemistry 33, 8991-8997]. To …

The NH2-terminal domain of uPAR has a primary role in uPA binding, although maintenance of its multidomain structure has been shown to be ne …

10

The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility.

Bugge TH, Suh TT, Flick MJ, Daugherty CC, Rømer J, Solberg H, Ellis V, Danø K, Degen JL. Bugge TH, et al. Among authors: ellis v. J Biol Chem. 1995 Jul 14;270(28):16886-94. doi: 10.1074/jbc.270.28.16886. J Biol Chem. 1995. PMID: 7622505 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters